Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-11-25 Sale | 2024-11-25 9:00 pm | Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER | 12,090 | $18.3 | $221,258 | 69,927 (Direct) | View |
| 2024-10-04 Sale | 2024-10-04 7:15 pm | Travere Therapeutics Inc. | TVTX | LYONS GARY A Director | 40,000 | $14.73 | $589,101 | 51,000 (Direct) | View |
| 2024-09-30 Sale | 2024-09-30 8:38 pm | Travere Therapeutics Inc. | TVTX | Meckler Jeffrey A Director | 40,000 | $14.06 | $562,324 | 81,000 (Direct) | View |
| 2024-09-10 Sale | 2024-09-10 4:05 pm | Travere Therapeutics Inc. | TVTX | Inrig Jula CHIEF MEDICAL OFFICER | 684 | $12.98 | $8,878 | 61,949 (Direct) | View |
| 2024-09-09 Sale | 2024-09-09 9:20 pm | Travere Therapeutics Inc. | TVTX | ROTE WILLIAM E. SENIOR VICE PRESIDENT, R&D | 4,387 | $11.52 | $50,538 | 84,455 (Direct) | View |
| 2024-09-09 Sale | 2024-09-09 9:20 pm | Travere Therapeutics Inc. | TVTX | REED ELIZABETH E SVP, GC & CORPORATE SECRETARY | 4,387 | $11.52 | $50,538 | 78,633 (Direct) | View |
| 2024-09-09 Sale | 2024-09-09 9:20 pm | Travere Therapeutics Inc. | TVTX | Dube Eric M CHIEF EXECUTIVE OFFICER | 21,125 | $11.52 | $243,360 | 361,975 (Direct) | View |
| 2024-09-09 Sale | 2024-09-09 9:20 pm | Travere Therapeutics Inc. | TVTX | Inrig Jula CHIEF MEDICAL OFFICER | 2,191 | $11.52 | $25,240 | 62,633 (Direct) | View |
| 2024-09-09 Sale | 2024-09-09 9:20 pm | Travere Therapeutics Inc. | TVTX | Heerma Peter CHIEF COMMERCIAL OFFICER | 2,191 | $11.52 | $25,240 | 107,958 (Direct) | View |
| 2024-09-09 Sale | 2024-09-09 9:20 pm | Travere Therapeutics Inc. | TVTX | Cline Christopher R. CHIEF FINANCIAL OFFICER | 2,490 | $11.52 | $28,685 | 74,595 (Direct) | View |
| 2024-09-04 Sale | 2024-09-05 9:30 pm | Travere Therapeutics Inc. | TVTX | Cline Christopher R. CHIEF FINANCIAL OFFICER | 514 | $9.5093 | $4,888 | 70,335 (Direct) | View |
| 2024-04-11 Sale | 2024-04-12 4:05 pm | Travere Therapeutics Inc. | TVTX | Cline Christopher R. CHIEF FINANCIAL OFFICER | 54 | $6.74 | $364 | 70,849 (Direct) | View |
| 2024-02-01 Sale | 2024-02-02 4:06 pm | Travere Therapeutics Inc. | TVTX | Dube Eric M CHIEF EXECUTIVE OFFICER | 19,122 | $8.7039 | $166,435 | 710,600 (Direct) | View |
| 2024-02-01 Sale | 2024-02-02 4:05 pm | Travere Therapeutics Inc. | TVTX | ROTE WILLIAM E. SENIOR VICE PRESIDENT, R&D | 4,764 | $8.7101 | $41,495 | 145,720 (Direct) | View |
| 2024-02-01 Sale | 2024-02-02 4:05 pm | Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER | 2,820 | $8.5312 | $24,058 | 77,017 (Direct) | View |
| 2024-02-01 Sale | 2024-02-02 4:05 pm | Travere Therapeutics Inc. | TVTX | REED ELIZABETH E SVP, GC & CORPORATE SECRETARY | 4,764 | $8.7102 | $41,495 | 141,270 (Direct) | View |
| 2024-02-01 Sale | 2024-02-02 4:05 pm | Travere Therapeutics Inc. | TVTX | Heerma Peter CHIEF COMMERCIAL OFFICER | 4,195 | $8.5313 | $35,789 | 164,503 (Direct) | View |
| 2024-02-01 Sale | 2024-02-02 4:05 pm | Travere Therapeutics Inc. | TVTX | Inrig Jula CHIEF MEDICAL OFFICER | 2,174 | $8.5311 | $18,547 | 149,074 (Direct) | View |
| 2024-02-01 Sale | 2024-02-02 4:05 pm | Travere Therapeutics Inc. | TVTX | Cline Christopher R. CHIEF FINANCIAL OFFICER | 3,818 | $8.5313 | $32,573 | 135,903 (Direct) | View |
| 2024-01-23 Sale | 2024-01-25 4:10 pm | Travere Therapeutics Inc. | TVTX | REED ELIZABETH E SVP, GC & CORPORATE SECRETARY | 2,062 | $8.96 | $18,476 | 56,034 (Direct) | View |
| 2024-01-23 Sale | 2024-01-25 4:10 pm | Travere Therapeutics Inc. | TVTX | Dube Eric M CHIEF EXECUTIVE OFFICER | 7,873 | $8.96 | $70,542 | 234,722 (Direct) | View |
| 2024-01-23 Sale | 2024-01-25 4:10 pm | Travere Therapeutics Inc. | TVTX | Cline Christopher R. CHIEF FINANCIAL OFFICER | 853 | $9.0684 | $7,735 | 49,721 (Direct) | View |
| 2024-01-23 Sale | 2024-01-25 4:10 pm | Travere Therapeutics Inc. | TVTX | ROTE WILLIAM E. SENIOR VICE PRESIDENT, R&D | 2,062 | $8.96 | $18,476 | 60,484 (Direct) | View |
| 2024-01-23 Sale | 2024-01-25 4:10 pm | Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER | 910 | $9.0684 | $8,252 | 41,337 (Direct) | View |
| 2024-01-23 Sale | 2024-01-25 4:10 pm | Travere Therapeutics Inc. | TVTX | Heerma Peter CHIEF COMMERCIAL OFFICER | 1,559 | $9.0684 | $14,138 | 78,698 (Direct) | View |
| 2024-01-03 Sale | 2024-01-05 4:11 pm | Travere Therapeutics Inc. | TVTX | Inrig Jula Chief Medical Officer | 2,509 | $9.4251 | $23,648 | 35,248 (Direct) | View |
| 2023-10-03 Sale | 2023-10-04 4:05 pm | Travere Therapeutics Inc. | TVTX | Heerma Peter Chief Commercial Officer | 3,091 | $8.2511 | $25,504 | 80,257 (Direct) | View |
| 2023-09-05 Sale | 2023-09-05 8:15 pm | Travere Therapeutics Inc. | TVTX | Cline Christopher R. Chief Financial Officer | 457 | $14.71 | $6,723 | 50,574 (Direct) | View |
| 2023-09-05 Sale | 2023-09-05 8:13 pm | Travere Therapeutics Inc. | TVTX | ROTE WILLIAM E. Senior Vice President, R&D | 1,815 | $14.71 | $26,699 | 61,173 (Direct) | View |
| 2023-09-05 Sale | 2023-09-05 8:12 pm | Travere Therapeutics Inc. | TVTX | REED ELIZABETH E SVP, GC & Corporate Secretary | 1,815 | $14.71 | $26,699 | 58,096 (Direct) | View |
| 2023-09-05 Sale | 2023-09-05 8:10 pm | Travere Therapeutics Inc. | TVTX | Dube Eric M Chief Executive Officer | 4,455 | $14.71 | $65,533 | 242,595 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-11-25 Exercise | 2024-11-25 9:00 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER | 15,000 | $12.67 | 69,927 (Direct) | View |
| 2024-11-25 Exercise | 2024-11-25 9:00 pm | N/A 2025-01-02 | Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER | 15,000 | $0 | 69,927 (Direct) | View |
| 2024-10-04 Exercise | 2024-10-04 7:15 pm | N/A 2024-10-08 | Travere Therapeutics Inc. | TVTX | LYONS GARY A Director | 40,000 | $0 | 51,000 (Direct) | View |
| 2024-10-04 Exercise | 2024-10-04 7:15 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | LYONS GARY A Director | 40,000 | $10.48 | 51,000 (Direct) | View |
| 2024-09-30 Exercise | 2024-09-30 8:38 pm | N/A 2024-10-08 | Travere Therapeutics Inc. | TVTX | Meckler Jeffrey A Director | 40,000 | $0 | 81,000 (Direct) | View |
| 2024-09-30 Exercise | 2024-09-30 8:38 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Meckler Jeffrey A Director | 40,000 | $10.48 | 81,000 (Direct) | View |
| 2024-09-05 Option Award | 2024-09-09 9:20 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | ROTE WILLIAM E. SENIOR VICE PRESIDENT, R&D | 6,750 | $0 | 84,455 (Direct) | View |
| 2024-09-05 Option Award | 2024-09-09 9:20 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | REED ELIZABETH E SVP, GC & CORPORATE SECRETARY | 6,750 | $0 | 78,633 (Direct) | View |
| 2024-09-05 Option Award | 2024-09-09 9:20 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Dube Eric M CHIEF EXECUTIVE OFFICER | 32,500 | $0 | 361,975 (Direct) | View |
| 2024-09-05 Option Award | 2024-09-09 9:20 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Inrig Jula CHIEF MEDICAL OFFICER | 6,750 | $0 | 62,633 (Direct) | View |
| 2024-09-05 Option Award | 2024-09-09 9:20 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Heerma Peter CHIEF COMMERCIAL OFFICER | 6,750 | $0 | 107,958 (Direct) | View |
| 2024-09-05 Option Award | 2024-09-09 9:20 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Cline Christopher R. CHIEF FINANCIAL OFFICER | 6,750 | $0 | 74,595 (Direct) | View |
| 2024-05-08 Option Award | 2024-05-10 4:06 pm | 2025-05-08 2034-05-07 | Travere Therapeutics Inc. | TVTX | Squarer Ron Director | 26,000 | $0 | 48,375 (Direct) | View |
| 2024-05-08 Option Award | 2024-05-10 4:06 pm | 2025-05-08 2034-05-07 | Travere Therapeutics Inc. | TVTX | Williams Brinkley Ruth Director | 26,000 | $0 | 38,750 (Direct) | View |
| 2024-05-08 Option Award | 2024-05-10 4:06 pm | 2025-05-08 2034-05-07 | Travere Therapeutics Inc. | TVTX | Orwin John A Director | 26,000 | $0 | 48,375 (Direct) | View |
| 2024-05-08 Option Award | 2024-05-10 4:05 pm | 2025-05-08 2034-05-07 | Travere Therapeutics Inc. | TVTX | Poole Sandra Director | 26,000 | $0 | 43,000 (Direct) | View |
| 2024-05-08 Option Award | 2024-05-10 4:05 pm | 2025-05-08 2034-05-07 | Travere Therapeutics Inc. | TVTX | Meckler Jeffrey A Director | 26,000 | $0 | 100,500 (Direct) | View |
| 2024-05-08 Option Award | 2024-05-10 4:05 pm | 2025-05-08 2034-05-07 | Travere Therapeutics Inc. | TVTX | LYONS GARY A Director | 26,000 | $0 | 70,500 (Direct) | View |
| 2024-05-08 Option Award | 2024-05-10 4:05 pm | 2025-05-08 2034-05-07 | Travere Therapeutics Inc. | TVTX | COUGHLIN TIMOTHY Director | 26,000 | $0 | 68,500 (Direct) | View |
| 2024-05-08 Option Award | 2024-05-10 4:05 pm | 2025-05-08 2034-05-07 | Travere Therapeutics Inc. | TVTX | Bruhn Suzanne Louise Director | 26,000 | $0 | 41,750 (Direct) | View |
| 2024-05-08 Option Award | 2024-05-10 4:05 pm | 2025-05-08 2034-05-07 | Travere Therapeutics Inc. | TVTX | Baynes Roy D. Director | 26,000 | $0 | 50,500 (Direct) | View |
| 2024-01-31 Option Award | 2024-02-02 4:06 pm | N/A 2034-01-30 | Travere Therapeutics Inc. | TVTX | Dube Eric M CHIEF EXECUTIVE OFFICER | 495,000 | $0 | 710,600 (Direct) | View |
| 2024-01-31 Option Award | 2024-02-02 4:05 pm | N/A 2034-01-30 | Travere Therapeutics Inc. | TVTX | ROTE WILLIAM E. SENIOR VICE PRESIDENT, R&D | 90,000 | $0 | 145,720 (Direct) | View |
| 2024-01-31 Option Award | 2024-02-02 4:05 pm | N/A 2034-01-30 | Travere Therapeutics Inc. | TVTX | Calvin Sandra SVP, CHIEF ACCOUNTING OFFICER | 38,500 | $0 | 77,017 (Direct) | View |
| 2024-01-31 Option Award | 2024-02-02 4:05 pm | N/A 2034-01-30 | Travere Therapeutics Inc. | TVTX | REED ELIZABETH E SVP, GC & CORPORATE SECRETARY | 90,000 | $0 | 141,270 (Direct) | View |
| 2024-01-31 Option Award | 2024-02-02 4:05 pm | N/A 2034-01-30 | Travere Therapeutics Inc. | TVTX | Heerma Peter CHIEF COMMERCIAL OFFICER | 90,000 | $0 | 164,503 (Direct) | View |
| 2024-01-31 Option Award | 2024-02-02 4:05 pm | N/A 2034-01-30 | Travere Therapeutics Inc. | TVTX | Inrig Jula CHIEF MEDICAL OFFICER | 116,000 | $0 | 149,074 (Direct) | View |
| 2024-01-31 Option Award | 2024-02-02 4:05 pm | N/A 2034-01-30 | Travere Therapeutics Inc. | TVTX | Cline Christopher R. CHIEF FINANCIAL OFFICER | 90,000 | $0 | 135,903 (Direct) | View |
| 2023-08-31 Option Award | 2023-09-05 8:13 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | ROTE WILLIAM E. Senior Vice President, R&D | 3,300 | $0 | 61,173 (Direct) | View |
| 2023-08-31 Option Award | 2023-09-05 8:12 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | REED ELIZABETH E SVP, GC & Corporate Secretary | 3,300 | $0 | 58,096 (Direct) | View |
| 2023-08-31 Option Award | 2023-09-05 8:10 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | Dube Eric M Chief Executive Officer | 9,900 | $0 | 242,595 (Direct) | View |